# POSACONAZOLE
> **ANDA214321** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2022-12-08
## Drug
- **FDA Application Number:** ANDA214321
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POSACONAZOLE
- **Generic name:** POSACONAZOLE
- **Active ingredients:** POSACONAZOLE
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD III
- **Manufacturer:** NorthStar RxLLC
- **First approval:** 2022-12-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214321)
---
*AI Analytics · CC0 1.0*